Researchers evaluated opioid use disorder hospitalizations and associated healthcare utilization outcomes in patients with common musculoskeletal diseases.
Gout was not found to be associated with increased risk for cardiovascular complications in patients with peripheral artery disease.
Researchers evaluated the properties and locations of color-coded dual-energy lesions in patients with gout.
Researchers examined the efficacy and safety of pegloticase in combination with methotrexate in patients with uncontrolled gout.
Researchers determined the real-world incidence of acute gout prophylaxis (AGP) while prescribing a xanthine oxidase inhibitor, and described the characteristics of AGP prescribing in reducing gout flares.
Thanks to their continued efforts, and a willingness to share their findings through published research, experts are advancing the cause of improved care for patients with gout.
Researchers assessed whether febuxostat increased the risk of developing cardiovascular events, death from cardiac-cause, and all-cause mortalities.
Researchers investigated the association between gout, urate-lowering therapy use, and the risk of developing type 2 diabetes.
Researchers evaluated the adrenocorticotropic hormone as an alternative therapeutic option for acute gout, and its potential mechanisms of action.
Patients with gout receiving urate lowering therapy by a treat-to-target approach demonstrate a reduced burden of monosodium urate crystals detected on ultrasound.